| Followers | 843 |
| Posts | 123009 |
| Boards Moderated | 9 |
| Alias Born | 09/05/2002 |
Saturday, June 29, 2024 4:29:01 PM
SOLV 1Q24 Results by Business Segment
*Includes components for other companies’ medical devices.
%Corp YoY Growth
Segment Sales (const currency)
Medical/surgical* 56% flat
Dental 17% flat
Health-info systems 16% flat
Purification/filtration 12% +7%
“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Recent SOLV News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 08:14:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:10:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:09:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/15/2026 08:07:54 PM
- Solventum to Participate in the 2026 BofA Securities Health Care Conference • PR Newswire (US) • 05/07/2026 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/05/2026 09:29:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/05/2026 08:08:36 PM
- Solventum Reports First Quarter 2026 Financial Results • PR Newswire (US) • 05/05/2026 08:05:00 PM
- Trian Calls on Solventum's Board to Create Value; Publishes Open Letter and Slide Deck • GlobeNewswire Inc. • 04/30/2026 05:05:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/30/2026 04:59:19 PM
- Solventum to Report First Quarter Fiscal 2026 Earnings on May 5, 2026 • PR Newswire (US) • 04/14/2026 08:05:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 03/27/2026 08:17:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:35:11 PM
- Solventum to Participate in the 2026 KeyBanc Healthcare Forum • PR Newswire (US) • 03/11/2026 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:49:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2026 11:47:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2026 09:08:05 PM
- Solventum Reports Fourth Quarter 2025 Financial Results and Introduces 2026 Full-Year Guidance • PR Newswire (US) • 02/26/2026 09:05:00 PM
- Solventum to Report Fourth Quarter and Full Year Fiscal 2025 Earnings on February 26, 2026 • PR Newswire (US) • 02/03/2026 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/03/2026 03:01:46 PM
- Solventum Completes Acquisition of Acera Surgical • PR Newswire (US) • 12/23/2025 09:05:00 PM
- Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy • PR Newswire (US) • 12/17/2025 09:05:00 PM
- Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength • PR Newswire (US) • 12/16/2025 09:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 02:02:04 PM
